Precision Biosciences's three largest insider shareholders as of March 23, 2026 are Derek Jantz (Chief Scientific Officer, 4.06Mn shares), Matthew R. Kane (President And Ceo, 2.01Mn shares), Michael Amoroso (President And Ceo, 243.39K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Derek Jantz | Chief Scientific Officer | 4,055,174 | 0 | 09 Jun, 2022 |
| Matthew R. Kane | President And Ceo | 2,013,597 | 0 | 14 May, 2021 |
| Michael Amoroso | President And Ceo | 243,392 | 0 | 19 Feb, 2026 |
| John Alexander Kelly | Chief Financial Officer | 125,883 | 0 | 19 Feb, 2026 |
| J. Jefferson Smith | Chief Research Officer | 121,926 | 0 | 19 Feb, 2026 |
| David S. Thomson | Chief Operating Officer | 111,513 | 0 | 25 Jun, 2021 |
| Dario Scimeca | General Counsel And Secretary | 56,457 | 0 | 19 Feb, 2026 |
| Kevin Buehler | 28,137 | 0 | 27 Jun, 2025 | |
| Shane Barton | Vp Corporate Controller | 27,502 | 0 | 09 Jun, 2023 |
| Geno J Germano | 23,883 | 0 | 17 Dec, 2025 | |
| Melinda Brown | 23,346 | 0 | 17 Dec, 2025 | |
| Stanley Frankel | 19,478 | 0 | 17 Dec, 2025 | |
| Shari Lisa Pire | 14,028 | 0 | 04 Jun, 2025 | |
| Alan List | Chief Medical Officer | 4,488 | 0 | 03 May, 2024 |
| Samuel C. Wadsworth | 4,202 | 0 | 07 May, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 17 Feb, 2026 | John Alexander Kelly | Common Stock | A | 27,584 | $0.00 | 134,032 | D | M |
| 17 Feb, 2026 | Michael Amoroso | Common Stock | A | 67,797 | $0.00 | 263,951 | D | M |
| 17 Feb, 2026 | J. Jefferson Smith | Common Stock | A | 16,667 | $0.00 | 126,851 | D | M |
| 17 Feb, 2026 | Dario Scimeca | Common Stock | A | 16,667 | $0.00 | 61,382 | D | M |
| 18 Feb, 2026 | John Alexander Kelly | Common Stock | D | 8,149 | $3.84 | 125,883 | D | S |
| 18 Feb, 2026 | Dario Scimeca | Common Stock | D | 4,925 | $3.84 | 56,457 | D | S |
| 18 Feb, 2026 | Michael Amoroso | Common Stock | D | 20,559 | $3.84 | 243,392 | D | S |
| 18 Feb, 2026 | J. Jefferson Smith | Common Stock | D | 4,925 | $3.84 | 121,926 | D | S |
| 17 Feb, 2026 | John Alexander Kelly | Restricted Stock Units | D | 27,584 | $0.00 | 55,166 | D | M |
| 17 Feb, 2026 | Dario Scimeca | Restricted Stock Units | D | 16,667 | $0.00 | 33,333 | D | M |
| 17 Feb, 2026 | Michael Amoroso | Restricted Stock Units | D | 67,797 | $0.00 | 135,593 | D | M |
| 17 Feb, 2026 | J. Jefferson Smith | Restricted Stock Units | D | 16,667 | $0.00 | 33,333 | D | M |
| 20 Jan, 2026 | John Alexander Kelly | Common Stock | A | 3,888 | - | 81,186 | D | M |
| 20 Jan, 2026 | J. Jefferson Smith | Common Stock | A | 2,500 | - | 93,718 | D | M |
| 20 Jan, 2026 | Dario Scimeca | Common Stock | A | 1,978 | $0.00 | 30,236 | D | M |
| 20 Jan, 2026 | Michael Amoroso | Common Stock | A | 8,888 | - | 124,463 | D | M |
| 20 Jan, 2026 | Dario Scimeca | Common Stock | A | 8,425 | $0.00 | 38,661 | D | M |
| 20 Jan, 2026 | J. Jefferson Smith | Common Stock | A | 10,447 | - | 104,165 | D | M |
| 20 Jan, 2026 | John Alexander Kelly | Common Stock | A | 13,900 | - | 95,086 | D | M |
| 20 Jan, 2026 | Michael Amoroso | Common Stock | A | 37,069 | - | 161,532 | D | M |